UK-based OCT developer Michelson opens US office

JUNE 24, 2009--Michelson Diagnostics Ltd. (MDL; Orpington, UK) has opened a U.S. sales and support office in Fuquay-Varina, NC, in the Research Triangle vicinity of Raleigh-Durham. The office is headed by Kevin C. Oakley, Michelson's new Business Development Manager (US). The office will act as a hub for growth of MDL's business in the field of optical coherence tomography (OCT) imaging.

OCT has great applications potential in fields such as skin cancer diagnosis, genetics research and tissue engineering development. In fact, Michelson has demonstrated its handheld-probe system for skin imaging at recent trade shows. The company has no FDA-approved clinical products yet, but is selling an OCT microscope for the scientific research market and recently announced the VivoSight in-vivo OCT system, for which it expects clinical approvals to be granted in Europe imminently.

"We already have US sales and are experiencing rapid growth of US enquiries in multiple market segments," said Jon Holmes, CEO of Michelson Diagnostics Ltd, "so it makes sense for us to establish a US presence to enable us to pursue these opportunities more effectively and to provide US customers with local support and service."

Oakley, is an experienced medical imaging executive with a background in expanding markets and growing sales for small companies with highly innovative medical imaging products. His career includes senior executive positions at Richardson Electronics Ltd. (Medical SBU), InfiMed, Inc., Lodox Systems, Ltd., and TeraRecon Inc.

For further information contact Oakley at or +1 (315) 783-3803, or visit Michelson Diagnostics' website.

Posted by Barbara G. Goode,, for BioOptics World.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

NIR spectroscopy intravascular imaging system receives $25M investment

Medical device maker Infraredx has received a $25 million equity investment from Nipro Corporation, which builds on an exclusive agreement between the two companies for distribution of Infraredx's ...

OCT pioneer Fujimoto selected as 2014 IEEE Photonics Award winner

James Fujimoto, the Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (MIT), has been selected for the 2014 IEEE Photonics Award.

OCT combo system receives FDA clearance, begins shipping worldwide

Ophthalmic device maker Optovue has received FDA 510(k) clearance for its iFusion combination system, which pairs the company's iVue spectral-domain optical coherence tomography (SD-OCT) system and...

OCT symposium emphasizes key applications

Overviews of biomedical imaging in general, and optical coherence tomography (OCT) in particular, kicked off the first international symposium hosted last week by the Center for Biomedical OCT Rese...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World